Compare MSBI & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSBI | PGEN |
|---|---|---|
| Founded | 1881 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 315.4M | 1.5B |
| IPO Year | 2016 | N/A |
| Metric | MSBI | PGEN |
|---|---|---|
| Price | $21.30 | $3.67 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $19.67 | $7.67 |
| AVG Volume (30 Days) | 215.1K | ★ 4.1M |
| Earning Date | 01-22-2026 | 11-13-2025 |
| Dividend Yield | ★ 6.01% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $210,718,000.00 | $6,309,000.00 |
| Revenue This Year | $28.11 | $342.78 |
| Revenue Next Year | N/A | $478.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 59.20 |
| 52 Week Low | $14.24 | $0.65 |
| 52 Week High | $26.97 | $5.23 |
| Indicator | MSBI | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 80.54 | 48.12 |
| Support Level | $19.54 | $3.42 |
| Resistance Level | $20.24 | $3.75 |
| Average True Range (ATR) | 0.73 | 0.23 |
| MACD | 0.47 | -0.02 |
| Stochastic Oscillator | 98.29 | 50.00 |
Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.